Yimu Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yimu Zhao has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Daniel Hocevar
Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, Canada
2 shared publications- Ilya Yakavets
Department of Chemistry, University of Toronto, 80 Saint George Street, Toronto, ON M5S 3H6, Canada
2 shared publications - Milica Radisic
Institute of Biomedical Engineering, University of Toronto, Toronto, Canada
2 shared publications - Amid Shakeri
Institute of Biomedical Engineering, University of Toronto, 27 King’s College Circle, Toronto, Canada
1 shared publication Boyang Zhang
School of Biomedical Engineering, McMaster University, 1280 Main Street West, Hamilton, ON, L8S 4L8, Canada; Department of Chemical Engineering, McMaster University, 1280 Main Street West, Hamilton, ON, L8S 4L8, Canada
1 shared publicationCaner Dikyol
Institute of Biomedical Engineering, University of Toronto, Toronto, Canada
1 shared publication
Latest Publications
- 9 November 2026
- Published by Springer Nature in Nature Reviews Bioengineering
- p. 1-3
Open-source hardware for biomanufacturing
- 9 November 2026
- Published by Springer Nature in Nature Reviews Bioengineering
- p. 1-3
Open-source hardware for biomanufacturing
- Open Access
- 24 February 2026
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 232, 115835
From conventional screening to self-driving discovery: Organ-on-Chip platforms as engines for AI-guided nanomedicine
- 24 February 2026
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 232, 115835
Open AccessFrom conventional screening to self-driving discovery: Organ-on-Chip platforms as engines for AI-guided nanomedicine
- Open Access
- 1 February 2025
- Published by KEAI Publishing in Bioactive Materials
- Vol. 44, 411-427
Cell driven elastomeric particle packing in composite bioinks for engineering and implantation of stable 3D printed structures
Geometric and structural integrity often deteriorate in 3D printed cell-laden constructs over time due to cellular compaction and hydrogel shrinkage. This study introduces a new approach that synergizes the advantages of cell compatibility of biological hydrogels and mechanical stability of elastomeric polymers for structure fidelity maintenance upon stereolithography and extrusion 3D printing. Enabling this advance is the composite bioink, formulated by integrating elastomeric microparticles from poly(octamethylene maleate (anhydride) citrate) (POMaC) into biologically derived hydrogels (fibrin, gelatin methacryloyl (GelMA), and alginate). The composite bioink enhanced the elasticity and plasticity of the 3D printed constructs, effectively mitigating tissue compaction and swelling. It exhibited a low shear modulus and a rapid crosslinking time, along with a high ultimate compressive strength and resistance to deformation from cellular forces and physical handling; this was attributed to packing and stress dissipation of elastomeric particles, which was confirmed via mathematical modelling. Enhanced functional assembly and stability of human iPSC-derived cardiac tissues and primary vasculature proved the utility of the composite bioink in tissue engineering. In vivo implantation studies revealed that constructs containing POMaC particles exhibited improved resilience against host tissue stress, enhanced angiogenesis, and infiltration of pro-reparative macrophages.
- 1 February 2025
- Published by KEAI Publishing in Bioactive Materials
- Vol. 44, 411-427
Open AccessCell driven elastomeric particle packing in composite bioinks for engineering and implantation of stable 3D printed structures
Geometric and structural integrity often deteriorate in 3D printed cell-laden constructs over time due to cellular compaction and hydrogel shrinkage. This study introduces a new approach that synergizes the advantages of cell compatibility of biological hydrogels and mechanical stability of elastomeric polymers for structure fidelity maintenance upon stereolithography and extrusion 3D printing. Enabling this advance is the composite bioink, formulated by integrating elastomeric microparticles from poly(octamethylene maleate (anhydride) citrate) (POMaC) into biologically derived hydrogels (fibrin, gelatin methacryloyl (GelMA), and alginate). The composite bioink enhanced the elasticity and plasticity of the 3D printed constructs, effectively mitigating tissue compaction and swelling. It exhibited a low shear modulus and a rapid crosslinking time, along with a high ultimate compressive strength and resistance to deformation from cellular forces and physical handling; this was attributed to packing and stress dissipation of elastomeric particles, which was confirmed via mathematical modelling. Enhanced functional assembly and stability of human iPSC-derived cardiac tissues and primary vasculature proved the utility of the composite bioink in tissue engineering. In vivo implantation studies revealed that constructs containing POMaC particles exhibited improved resilience against host tissue stress, enhanced angiogenesis, and infiltration of pro-reparative macrophages.